VolitionRx Limited (VNRX) Stock Overview
Explore VolitionRx Limited’s financial performance, market position, analyst ratings, and future outlook.
VolitionRx Limited (VNRX)
Key Financials
Key Financials
Market Cap
8.1M
P/E Ratio
-0.39
EPS (TTM)
$-4.25
ROE
0.74%
VNRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of VolitionRx Limited (VNRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 45.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.39.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.39 and a market capitalization of 8.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.